Evidence map›Paper›PMID 40717090›Full record

ArticleOrphanet journal of rare diseases2025

Analysis of retrospective natural history data collected from patients with SYNGAP1-related disorders: a preliminary examination of the Citizen database.

Matthew R Scott, Albert Misko, Yang Liu, Oleksandr Sverdlov

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matthew R ScottDepartment of Biostatistics, School of Public Health, Boston University, Boston, MA, USA.
Albert MiskoNovartis Institutes for Biomedical Research, Cambridge, MA, USA.
Yang LiuNovartis Institutes for Biomedical Research, Cambridge, MA, USA.
Oleksandr SverdlovNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA. alex.sverdlov@novartis.com.ORCID http://orcid.org/0000-0002-1626-2588

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSYNGAP1-related disorder (SRD) is a rare neurodevelopmental disorder caused by genetic variants. A major challenge is the characterization of SRD, which requires assessment of several outcomes. We considered natural history data from the Citizen database on 65 patients with SRD in eight data domains: demographics, genetics, growth parameters, standardized clinical scales, developmental skills, neurological examinations, hospitalizations, and seizures. Exploratory analysis tools such as visualizations, summary statistics, and non-parametric statistical modeling were utilized.

resultsAge at SRD diagnosis (median [IQR] = 3 [2, 5] years; [min, max] = [1, 17] years) was similar by sex. No evidence of a high frequency allele change in SYNGAP1 was found, indicating no dominant variant in this patient population. Growth parameters of SRD children appeared normal in terms of height, weight, and head circumference. Developmental data were indicative of delayed development and language reversion. Standardized assessment data were largely sparse. Neurological exam data demonstrated ataxia and muscle tone issues. Hospitalization data highlighted substantial healthcare burden, largely due to seizures; absence, atonic, and myoclonic seizures were the most common types.

conclusionCitizen data provide important insights into the natural course of SRD. Our findings not only provide utility in clinical practice of SRD but also contribute valuable insights to guide the development of SRD clinical trials. Limitations to our analysis include sparsity of standardized clinical scales data, crude statistical methodology, and bias induced by patients with older ages of diagnoses.

Indexed as

ras GTPase-Activating ProteinsAdolescentChildChild, PreschoolDatabases, FactualFemaleHumansInfantMaleRetrospective Studiesras GTPase-Activating ProteinsSYNGAP1 protein, human

Identifiers

PMID40717090
PMCPMC12302738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.